{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T13:56:08Z","timestamp":1715608568309},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T00:00:00Z","timestamp":1532131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11739-018-1909-8","type":"journal-article","created":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T07:21:09Z","timestamp":1532157669000},"page":"1287-1303","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Secondary prevention of cryptogenic stroke in patients with patent foramen ovale: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"13","author":[{"given":"Elisa Maria","family":"Fiorelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Carandini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delia","family":"Gagliardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"Bozzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia","family":"Bonzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Tobaldini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo Pietro","family":"Comi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elio Angelo","family":"Scarpini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Montano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Solbiati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,21]]},"reference":[{"key":"1909_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0140-6736(13)61953-4","volume":"383","author":"VL Feigin","year":"2014","unstructured":"Feigin VL, Forouzanfar MH, Krishnamurthi R et al (2014) Global and regional burden of stroke during 1990\u20132010: findings from the Global Burden of Disease Study 2010. Lancet 383:245\u2013255. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(13)61953-4","journal-title":"Lancet"},{"key":"1909_CR2","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1161\/HS1101.098524","volume":"32","author":"AJ Grau","year":"2001","unstructured":"Grau AJ, Weimar C, Buggle F et al (2001) Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 32:2559\u20132566. \n                    https:\/\/doi.org\/10.1161\/HS1101.098524","journal-title":"Stroke"},{"key":"1909_CR3","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1161\/01.STR.30.12.2513","volume":"30","author":"GW Petty","year":"1999","unstructured":"Petty GW, Brown RD, Whisnant JP et al (1999) Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke 30:2513\u20132516. \n                    https:\/\/doi.org\/10.1161\/01.STR.30.12.2513","journal-title":"Stroke"},{"key":"1909_CR4","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1474-4422(15)00132-5","volume":"14","author":"L Li","year":"2015","unstructured":"Li L, Yiin GS, Geraghty OC et al (2015) Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. Lancet Neurol 14:903\u2013913. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(15)00132-5","journal-title":"Lancet Neurol"},{"key":"1909_CR5","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1161\/CIRCULATIONAHA.104.524371","volume":"112","author":"S Homma","year":"2005","unstructured":"Homma S, Sacco RL (2005) Patent foramen ovale and stroke. Circulation 112:1063\u20131072. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.524371","journal-title":"Circulation"},{"key":"1909_CR6","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1161\/STROKEAHA.109.547828","volume":"40","author":"AA Alsheikh-Ali","year":"2009","unstructured":"Alsheikh-Ali AA, Thaler DE, Kent DM (2009) Patent foramen ovale in cryptogenic stroke incidental or pathogenic? Stroke 40:2349\u20132355","journal-title":"Stroke"},{"key":"1909_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jcin.2012.02.021","volume":"5","author":"S Agarwal","year":"2012","unstructured":"Agarwal S, Bajaj NS, Kumbhani DJ et al (2012) Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism (Structured abstract). JACC Cardiovasc Interv 5:777\u2013789","journal-title":"JACC Cardiovasc Interv"},{"key":"1909_CR8","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1009639","volume":"366","author":"AJ Furlan","year":"2012","unstructured":"Furlan AJ, Reisman M, Massaro J et al (2012) Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 366:991\u2013999. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1009639","journal-title":"N Engl J Med"},{"key":"1909_CR9","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","volume":"368","author":"JD Carroll","year":"2013","unstructured":"Carroll JD, Saver JL, Thaler DE et al (2013) Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 368:1092\u20131100. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1301440","journal-title":"N Engl J Med"},{"key":"1909_CR10","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","volume":"368","author":"B Meier","year":"2013","unstructured":"Meier B, Kalesan B, Mattle HP et al (2013) Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 368:1083\u20131091. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1211716","journal-title":"N Engl J Med"},{"key":"1909_CR11","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jacc.2015.12.023","volume":"67","author":"DM Kent","year":"2016","unstructured":"Kent DM, Dahabreh IJ, Ruthazer R et al (2016) Device closure of patent foramen ovale after stroke. J Am Coll Cardiol 67:907\u2013917. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2015.12.023","journal-title":"J Am Coll Cardiol"},{"key":"1909_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.carrev.2013.08.010","volume":"14","author":"A Hakeem","year":"2013","unstructured":"Hakeem A, Marmagkiolis K, Hacioglu Y et al (2013) Safety and efficacy of device closure for patent foramen ovale for secondary prevention of neurological events: comprehensive systematic review and meta-analysis of randomized controlled trials (provisional abstract). Cardiovasc Revasc Med 14:349\u2013355","journal-title":"Cardiovasc Revasc Med"},{"key":"1909_CR13","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.jcin.2013.08.001","volume":"6","author":"AR Khan","year":"2013","unstructured":"Khan AR, Bin Abdulhak AA, Sheikh MA et al (2013) Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis. JACC Cardiovasc Interv 6:1316\u20131323. \n                    https:\/\/doi.org\/10.1016\/j.jcin.2013.08.001","journal-title":"JACC Cardiovasc Interv"},{"key":"1909_CR14","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1016\/j.ijcard.2013.07.077","volume":"168","author":"JSW Kwong","year":"2013","unstructured":"Kwong JSW, Lam Y-Y, Yu C-M (2013) Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials. Int J Cardiol 168:4132\u20134138. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2013.07.077","journal-title":"Int J Cardiol"},{"key":"1909_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd009938.pub2","author":"J Li","year":"2015","unstructured":"Li J, Liu J, Liu M et al (2015) Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.cd009938.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1909_CR16","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1093\/eurheartj\/eht285","volume":"34","author":"P Rengifo-Moreno","year":"2013","unstructured":"Rengifo-Moreno P, Palacios IF, Junpaparp P et al (2013) Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials. Eur Heart J 34:3342\u20133352. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/eht285","journal-title":"Eur Heart J"},{"issue":"7","key":"1909_CR17","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","volume":"45","author":"WN Kernan","year":"2014","unstructured":"Kernan WN, Ovbiagele B, Black HR et al (2014) Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 45(7):2160\u20132236. \n                    https:\/\/doi.org\/10.1161\/STR.0000000000000024","journal-title":"Stroke"},{"key":"1909_CR18","first-page":"95","volume":"2","author":"N Ahmed","year":"2017","unstructured":"Ahmed N, Steiner T, Caso V et al (2017) Recommendations from the ESO-karolinska stroke update conference, Stockholm 13\u201315 November 2016. Eur J 2:95\u2013102","journal-title":"Eur J"},{"key":"1909_CR19","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1212\/WNL.0b013e3182a08d59","volume":"81","author":"DM Kent","year":"2013","unstructured":"Kent DM, Ruthazer R, Weimar C et al (2013) An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology 81:619\u2013625. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3182a08d59","journal-title":"Neurology"},{"key":"1909_CR20","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","volume":"377","author":"J-L Mas","year":"2017","unstructured":"Mas J-L, Derumeaux G, Guillon B et al (2017) Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med 377:1011\u20131021. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1705915","journal-title":"N Engl J Med"},{"key":"1909_CR21","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","volume":"377","author":"L Sondergaard","year":"2017","unstructured":"Sondergaard L, Kasner SE, Rhodes JF et al (2017) Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med 377:1033\u20131042. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1707404","journal-title":"N Engl J Med"},{"key":"1909_CR22","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1161\/STROKEAHA.117.020030","volume":"49","author":"G Ntaios","year":"2018","unstructured":"Ntaios G, Papavasileiou V, Sagris D et al (2018) Closure of patent foramen ovale versus medical therapy in patients with cryptogenic stroke or transient ischemic attack: updated systematic review and meta-analysis. Stroke 49:412\u2013418. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.117.020030","journal-title":"Stroke"},{"key":"1909_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.7326\/M17-2679","volume":"168","author":"R Shah","year":"2018","unstructured":"Shah R, Nayyar M, Jovin IS et al (2018) Device closure versus medical therapy alone for patent foramen ovale in patients with cryptogenic stroke: a systematic review and meta-analysis. Ann Intern Med 168:335\u2013342. \n                    https:\/\/doi.org\/10.7326\/M17-2679","journal-title":"Ann Intern Med"},{"key":"1909_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.7326\/M17-3033","volume":"168","author":"S Rosa De","year":"2018","unstructured":"De Rosa S, Sievert H, Sabatino J et al (2018) Percutaneous closure versus medical treatment in stroke patients with patent foramen ovale: a systematic review and meta-analysis. Ann Intern Med 168:343\u2013350. \n                    https:\/\/doi.org\/10.7326\/M17-3033","journal-title":"Ann Intern Med"},{"key":"1909_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.amjcard.2017.11.037","volume":"121","author":"T Ando","year":"2018","unstructured":"Ando T, Holmes AA, Pahuja M et al (2018) Meta-analysis comparing patent foramen ovale closure versus medical therapy to prevent recurrent cryptogenic stroke. Am J Cardiol 121:649\u2013655. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2017.11.037","journal-title":"Am J Cardiol"},{"key":"1909_CR26","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","volume":"377","author":"JL Saver","year":"2017","unstructured":"Saver JL, Carroll JD, Thaler DE et al (2017) Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med 377:1022\u20131032. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1610057","journal-title":"N Engl J Med"},{"key":"1909_CR27","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/j.jcin.2017.09.002","volume":"10","author":"MK Mojadidi","year":"2017","unstructured":"Mojadidi MK, Elgendy AY, Elgendy IY et al (2017) Transcatheter patent foramen ovale closure after cryptogenic stroke. JACC Cardiovasc Interv 10:2228\u20132230. \n                    https:\/\/doi.org\/10.1016\/j.jcin.2017.09.002","journal-title":"JACC Cardiovasc Interv"},{"key":"1909_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2018.02.021","author":"A Smer","year":"2018","unstructured":"Smer A, Salih M, Mahfood Haddad T et al (2018) Meta-analysis of randomized controlled trials on patent foramen ovale closure versus medical therapy for secondary prevention of cryptogenic stroke. Am J Cardiol. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2018.02.021","journal-title":"Am J Cardiol"},{"key":"1909_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2018.02.021","author":"B Alushi","year":"2018","unstructured":"Alushi B, Lauten A, Cassese S et al (2018) Patent foramen ovale closure versus medical therapy for prevention of recurrent cryptogenic embolism: updated meta-analysis of randomized clinical trials Brunilda. Clin Res Cardiol. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2018.02.021","journal-title":"Clin Res Cardiol"},{"key":"1909_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2018.02.023","author":"TKM Wang","year":"2018","unstructured":"Wang TKM, Wang MTM, Ruygrok P (2018) Patent foramen ovale closure versus medical therapy for cryptogenic stroke: meta-analysis of randomised trials. Heart Lung Circ. \n                    https:\/\/doi.org\/10.1016\/j.hlc.2018.02.023","journal-title":"Heart Lung Circ"},{"key":"1909_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.27615","author":"AK Akobeng","year":"2018","unstructured":"Akobeng AK, Abdelgadir I, Boudjemline Y, Hijazi ZM (2018) Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: a systematic review and meta-analysis of randomized controlled trials. Catheter Cardiovasc Interv. \n                    https:\/\/doi.org\/10.1002\/ccd.27615","journal-title":"Catheter Cardiovasc Interv"},{"key":"1909_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy121","author":"Y Ahmad","year":"2018","unstructured":"Ahmad Y, Howard JP, Arnold A et al (2018) Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials. Eur Heart J. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehy121","journal-title":"Eur Heart J"},{"key":"1909_CR33","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s00415-018-8750-x","volume":"265","author":"E Abo-salem","year":"2018","unstructured":"Abo-salem E, Chaitman B, Helmy T et al (2018) Patent foramen ovale closure versus medical therapy in cases with cryptogenic stroke, meta-analysis of randomized controlled trials. J Neurol 265:578\u2013585. \n                    https:\/\/doi.org\/10.1007\/s00415-018-8750-x","journal-title":"J Neurol"},{"key":"1909_CR34","unstructured":"Song J-K NCT01550588. Device closure versus medical therapy for secondary prevention in cryptogenic stroke patients with high-risk patent foramen ovale: DEFENSE-PFO"},{"key":"1909_CR35","first-page":"94","volume":"18","author":"A Shariat","year":"2013","unstructured":"Shariat A, Yaghoubi E, Farazdaghi M et al (2013) Comparison of medical treatments in cryptogenic stroke patients with patent foramen ovale: a randomized clinical trial. J Res Med Sci 18:94\u201398","journal-title":"J Res Med Sci"},{"key":"1909_CR36","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1161\/01.CIR.0000017498.88393.44","volume":"105","author":"S Homma","year":"2002","unstructured":"Homma S, Sacco RL, Di Tullio MR et al (2002) Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 105:2625\u20132631","journal-title":"Circulation"},{"key":"1909_CR37","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1093\/eurheartj\/ehv252","volume":"36","author":"DM Kent","year":"2015","unstructured":"Kent DM, Dahabreh IJ, Ruthazer R et al (2015) Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis. Eur Heart J 36:2381\u20132389. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehv252","journal-title":"Eur Heart J"},{"key":"1909_CR38","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1371\/journal.pmed1000097","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Academia and clinic annals of internal medicine preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annu Intern Med 151:264\u2013269. \n                    https:\/\/doi.org\/10.1371\/journal.pmed1000097","journal-title":"Annu Intern Med"},{"key":"1909_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for systematic reviews of interventions","author":"JPT Higgins","year":"2008","unstructured":"Higgins JPT, Green S (2008) Cochrane Handbook for systematic reviews of interventions. Wiley, Chichester"},{"key":"1909_CR40","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","volume":"328","author":"D Atkins","year":"2004","unstructured":"Atkins D, Best D, Briss PA et al (2004) Grading quality of evidence and strength of recommendations. BMJ 328:1490. \n                    https:\/\/doi.org\/10.1136\/bmj.328.7454.1490","journal-title":"BMJ"},{"key":"1909_CR41","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/S0735-1097(01)01635-7","volume":"38","author":"F Attie","year":"2001","unstructured":"Attie F, Rosas M, Granados N et al (2001) Surgical treatment for secundum atrial septal defects in patients >\u200940\u00a0years old. J Am Coll Cardiol 38:2035\u20132042. \n                    https:\/\/doi.org\/10.1016\/S0735-1097(01)01635-7","journal-title":"J Am Coll Cardiol"},{"key":"1909_CR42","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.hlc.2013.07.022","volume":"22","author":"V Nagaraja","year":"2013","unstructured":"Nagaraja V, Raval J, Eslick GD et al (2013) Is transcatheter closure better than medical therapy for cryptogenic stroke with patent foramen ovale? A meta-analysis of randomised trials. Heart Lung Circ 22:903\u2013909. \n                    https:\/\/doi.org\/10.1016\/j.hlc.2013.07.022","journal-title":"Heart Lung Circ"},{"key":"1909_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ijcard.2013.08.058","volume":"169","author":"G Ntaios","year":"2013","unstructured":"Ntaios G, Papavasileiou V, Makaritsis K, Michel P (2013) PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis. Int J Cardiol 169:101\u2013105. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2013.08.058","journal-title":"Int J Cardiol"},{"key":"1909_CR44","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.hlc.2013.12.003","volume":"23","author":"A Pandit","year":"2014","unstructured":"Pandit A, Aryal MR, Pandit AA et al (2014) Amplatzer PFO occluder device may prevent recurrent stroke in patients with patent foramen ovale and cryptogenic stroke: a meta-analysis of randomised trials. Hear Lung Circ 23:303\u2013308. \n                    https:\/\/doi.org\/10.1016\/j.hlc.2013.12.003","journal-title":"Hear Lung Circ"},{"key":"1909_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-8766-2","author":"X Niu","year":"2018","unstructured":"Niu X, Ou-Yang G, Yan P et al (2018) Closure of patent foramen ovale for cryptogenic stroke patients: an updated systematic review and meta-analysis of randomized trials. J Neurol. \n                    https:\/\/doi.org\/10.1007\/s00415-018-8766-2","journal-title":"J Neurol"},{"key":"1909_CR46","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11739-012-0792-y","volume":"7","author":"F Perego","year":"2012","unstructured":"Perego F, Casazza G (2012) Why meta-analyses on the same topic lead to different conclusions? Intern Emerg Med 7:381\u2013383. \n                    https:\/\/doi.org\/10.1007\/s11739-012-0792-y","journal-title":"Intern Emerg Med"},{"key":"1909_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.27487","author":"A Hakeem","year":"2018","unstructured":"Hakeem A, Cilingiroglu M, Katramados A et al (2018) Transcatheter closure of patent foramen ovale for secondary prevention of ischemic stroke: quantitative synthesis of pooled randomized trial data. Catheter Cardiovasc Interv. \n                    https:\/\/doi.org\/10.1002\/ccd.27487","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-018-1909-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-018-1909-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-018-1909-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T23:17:36Z","timestamp":1563664656000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-018-1909-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,21]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1909"],"URL":"https:\/\/doi.org\/10.1007\/s11739-018-1909-8","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,21]]},"assertion":[{"value":"14 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human and animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}